An AHEI Dietary Intervention to Reduce Pain in Women with Endometriosis
AHEI 饮食干预可减轻子宫内膜异位症女性的疼痛
基本信息
- 批准号:10319593
- 负责人:
- 金额:$ 50.43万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2019
- 资助国家:美国
- 起止时间:2019-02-11 至 2024-12-31
- 项目状态:已结题
- 来源:
- 关键词:AbateAdherenceAffectAgeAlternative HealthAnalgesicsBed OccupancyBed restBehavioralBiological MarkersC-reactive proteinCarotenoidsControl GroupsDiagnosisDietDiet ModificationDietary FactorsDietary InterventionDietitianDiseaseEatingEducational process of instructingEffectivenessEndometrialEtiologyFoodFoundationsGoalsGuidelinesHealthHealth Care CostsHealthy EatingHomeHormonalIndividualInfertilityInflammationInflammatoryInstructionInterleukin-1 betaInterleukin-6InterventionMeasuresMetabolismMorbidity - disease rateNational Health Interview SurveyNurses&apos Health StudyObservational StudyOperative Surgical ProceduresOutcomePainParticipantPelvic PainPersonsPlasmaPremenopausePreparationPrevalenceProcessProductivityProstaglandinsPsyche structurePublicationsQuality of lifeQuestionnairesRandomizedRandomized, Controlled TrialsRecipeRecordsReportingResearchRiskRisk FactorsSF-12Smooth MuscleSurveysSymptomsTNFRSF1A geneTelephoneTestingTissuesTrainingUterine cavityUterusVisualVisual Analogue Pain ScaleWomanWorkagedanalogbiobankchronic pelvic paincostcytokinedietarydietary guidelinesdietary supplementsendometriosisevidence baseexperiencegroup interventionimprovedindexinginflammatory markerintervention effectmeetingsmodifiable riskpain catastrophizingpain reductionpain scorepain symptomphenomepillpsychologicrandomized controlled designreproductivesocialsymptomatologytelephone based
项目摘要
PROJECT SUMMARY/ABSTRACT
Endometriosis, a disorder characterized by the presence of endometrial-like tissue outside of the
uterus, affects approximately 10% of reproductive age women in the US. Despite its prevalence, the etiology of
endometriosis has not been fully delineated. It incurs significant health care costs and greatly impacts quality of
life (QOL). Over 80% of women with endometriosis report chronic pelvic pain (CPP) and symptoms are often
not sufficiently abated with hormonal suppression or surgery. Hence, the identification of other evidenced-
based, modifiable factors, that improve pain and QOL are critical to improving the lives of women with
endometriosis.
The goal of this study is to evaluate the effects of a 12-week dietary intervention among women with
laparoscopically-confirmed endometriosis who had a pain score of at least 7 out of 10 on the Visual Analog
Scale (VAS) in the month prior to baseline. The intervention will consist of a diet based on the Alternative
Health Eating Index-2010 (AHEI-2010) guidelines, as observational research suggests that adherence to the
AHEI-2010 may decrease risk of laparoscopically-diagnosed endometriosis among women experiencing pain
symptoms. The specific aims of the proposed study are to test the effect of the AHEI-2010 guideline-based
dietary intervention on: 1) the VAS pain score, the pain catastrophizing scale, and mean number of pain pills
taken per week; 2) physical and mental QOL components measured with the Endometriosis Health Profile
(EHP-30) Questionnaire and Short Form Survey (SF-12); 3) circulating levels of inflammatory markers (IL-6, IL-
1β, hs-CRP, sTNFR-1, sTNFR-2).
Women with laparoscopically-confirmed endometriosis (n=100) will be randomized to a 12-week dietary
intervention or a control group. The intervention group will have meal ingredients shipped to directly to their
home during the first 4 weeks of the intervention. For the remaining 8 weeks, meal plans and recipes will be
provided. Pain, quality of life, and inflammatory markers will be assessed at baseline, 4, 8, and 12-weeks using
validated questionnaires following the guidelines of the World Endometriosis Research Foundation (WERF)
Endometriosis Phenome and Biobanking Harmonization Project (EPHect). In addition, longer-term effects of
the intervention will be assessed by examining pain and QOL outcomes at 6 months and 1 year.
Many women with endometriosis experience poor QOL due to chronic pelvic pain and other physical
and mental sequelae of endometriosis. As symptoms are often not sufficiently abated with hormonal
suppression or surgery, the identification of other evidenced-based, modifiable factors, that improve pain and
QOL are critical to improving the lives of women with endometriosis.
项目摘要/摘要
子宫内膜异位症,一种以子宫内膜外存在子宫内膜样组织为特征的疾病,
子宫,影响了美国约10%的育龄妇女。尽管它的流行,
子宫内膜异位症尚未完全阐明。它会产生大量的医疗保健费用,并极大地影响医疗保健的质量。
生活质量(QOL)。超过80%患有子宫内膜异位症的女性报告慢性盆腔疼痛(CPP),症状通常是
激素抑制或手术不能充分缓解。因此,其他证据的识别-
基础的,可改变的因素,改善疼痛和生活质量是至关重要的,以改善妇女的生活,
子宫内膜异位症
这项研究的目的是评估12周的饮食干预对患有糖尿病的女性的影响。
腹腔镜下确诊的子宫内膜异位症,视觉模拟疼痛评分至少为7分(满分10分)
基线前一个月的VAS评分。干预措施将包括基于替代方案的饮食
健康饮食指数-2010(AHEI-2010)指南,因为观察性研究表明,
AHEI-2010可能会降低经历疼痛的女性腹腔镜诊断子宫内膜异位症的风险
症状拟议研究的具体目标是测试AHEI-2010指南为基础的
饮食干预:1)VAS疼痛评分、疼痛灾难化量表和止痛药的平均数量
2)用子宫内膜异位症健康状况量表测量的身体和精神QOL成分
(EHP-30)问卷和简明调查表(SF-12); 3)炎症标志物(IL-6、IL-12)的循环水平
1β、hs-CRP、sTNFR-1、sTNFR-2)。
经腹腔镜证实的子宫内膜异位症女性患者(n=100)将被随机分配至12周的饮食
干预组或对照组。干预组将有膳食成分直接运送到他们的
在干预的前4周内回家。在剩下的8周里,膳食计划和食谱将
提供了将在基线、第4、8和12周时使用以下方法评估疼痛、生活质量和炎症标志物:
根据世界子宫内膜异位症研究基金会(WERF)的指导方针,
子宫内膜异位症表型组和生物库协调项目(EPHect)。此外,长期影响
将通过检查6个月和1年时的疼痛和QOL结果来评估干预。
许多患有子宫内膜异位症的女性由于慢性盆腔疼痛和其他身体原因而经历较差的生活质量
以及子宫内膜异位症的精神后遗症由于激素治疗往往不能充分缓解症状,
抑制或手术,识别其他基于证据的,可改变的因素,改善疼痛,
生活质量对改善子宫内膜异位症妇女的生活至关重要。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Holly Ruth Harris其他文献
Holly Ruth Harris的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Holly Ruth Harris', 18)}}的其他基金
Type II diabetes, related biomarkers and medications, and ovarian cancer risk
II 型糖尿病、相关生物标志物和药物以及卵巢癌风险
- 批准号:
10601473 - 财政年份:2022
- 资助金额:
$ 50.43万 - 项目类别:
Erythrocyte fatty acids and risk of endometriosis
红细胞脂肪酸与子宫内膜异位症的风险
- 批准号:
10527106 - 财政年份:2022
- 资助金额:
$ 50.43万 - 项目类别:
Type II diabetes, related biomarkers and medications, and ovarian cancer risk
II 型糖尿病、相关生物标志物和药物以及卵巢癌风险
- 批准号:
10551238 - 财政年份:2022
- 资助金额:
$ 50.43万 - 项目类别:
Type II diabetes, related biomarkers and medications, and ovarian cancer risk
II 型糖尿病、相关生物标志物和药物以及卵巢癌风险
- 批准号:
10357268 - 财政年份:2022
- 资助金额:
$ 50.43万 - 项目类别:
An AHEI Dietary Intervention to Reduce Pain in Women with Endometriosis
AHEI 饮食干预可减轻子宫内膜异位症女性的疼痛
- 批准号:
10604795 - 财政年份:2019
- 资助金额:
$ 50.43万 - 项目类别:
An AHEI Dietary Intervention to Reduce Pain in Women with Endometriosis
AHEI 饮食干预可减轻子宫内膜异位症女性的疼痛
- 批准号:
10078876 - 财政年份:2019
- 资助金额:
$ 50.43万 - 项目类别:
PCOS, Type II diabetes and ovarian cancer risk
PCOS、II 型糖尿病和卵巢癌风险
- 批准号:
8869433 - 财政年份:2016
- 资助金额:
$ 50.43万 - 项目类别:
PCOS, Type II diabetes and ovarian cancer risk
PCOS、II 型糖尿病和卵巢癌风险
- 批准号:
9302318 - 财政年份:2016
- 资助金额:
$ 50.43万 - 项目类别:
相似海外基金
An innovative, AI-driven prehabilitation platform that increases adherence, enhances post-treatment outcomes by at least 50%, and provides cost savings of 95%.
%20创新、%20AI驱动%20康复%20平台%20%20增加%20依从性、%20增强%20治疗后%20结果%20by%20at%20至少%2050%、%20和%20提供%20成本%20节省%20of%2095%
- 批准号:
10057526 - 财政年份:2023
- 资助金额:
$ 50.43万 - 项目类别:
Grant for R&D
Improving Repositioning Adherence in Home Care: Supporting Pressure Injury Care and Prevention
提高家庭护理中的重新定位依从性:支持压力损伤护理和预防
- 批准号:
490105 - 财政年份:2023
- 资助金额:
$ 50.43万 - 项目类别:
Operating Grants
I-Corps: Medication Adherence System
I-Corps:药物依从性系统
- 批准号:
2325465 - 财政年份:2023
- 资助金额:
$ 50.43万 - 项目类别:
Standard Grant
Unintrusive Pediatric Logging Orthotic Adherence Device: UPLOAD
非侵入式儿科记录矫形器粘附装置:上传
- 批准号:
10821172 - 财政年份:2023
- 资助金额:
$ 50.43万 - 项目类别:
Nuestro Sueno: Cultural Adaptation of a Couples Intervention to Improve PAP Adherence and Sleep Health Among Latino Couples with Implications for Alzheimer’s Disease Risk
Nuestro Sueno:夫妻干预措施的文化适应,以改善拉丁裔夫妇的 PAP 依从性和睡眠健康,对阿尔茨海默病风险产生影响
- 批准号:
10766947 - 财政年份:2023
- 资助金额:
$ 50.43万 - 项目类别:
CO-LEADER: Intervention to Improve Patient-Provider Communication and Medication Adherence among Patients with Systemic Lupus Erythematosus
共同领导者:改善系统性红斑狼疮患者的医患沟通和药物依从性的干预措施
- 批准号:
10772887 - 财政年份:2023
- 资助金额:
$ 50.43万 - 项目类别:
Pharmacy-led Transitions of Care Intervention to Address System-Level Barriers and Improve Medication Adherence in Socioeconomically Disadvantaged Populations
药房主导的护理干预转型,以解决系统层面的障碍并提高社会经济弱势群体的药物依从性
- 批准号:
10594350 - 财政年份:2023
- 资助金额:
$ 50.43万 - 项目类别:
Antiretroviral therapy adherence and exploratory proteomics in virally suppressed people with HIV and stroke
病毒抑制的艾滋病毒和中风患者的抗逆转录病毒治疗依从性和探索性蛋白质组学
- 批准号:
10748465 - 财政年份:2023
- 资助金额:
$ 50.43万 - 项目类别:
Improving medication adherence and disease control for patients with multimorbidity: the role of price transparency tools
提高多病患者的药物依从性和疾病控制:价格透明度工具的作用
- 批准号:
10591441 - 财政年份:2023
- 资助金额:
$ 50.43万 - 项目类别:
Development and implementation of peer-facilitated decision-making and referral support to increase uptake and adherence to HIV pre-exposure prophylaxis in African Caribbean and Black communities in Ontario
制定和实施同行协助决策和转介支持,以提高非洲加勒比地区和安大略省黑人社区对艾滋病毒暴露前预防的接受和依从性
- 批准号:
491109 - 财政年份:2023
- 资助金额:
$ 50.43万 - 项目类别:
Fellowship Programs